Concepedia

Gyula Ostoros

GO

37

Publications

13.4K

Citations

26

H-Index

2002

Active since

Affiliations

Országos Korányi Tbc és Pulmonológiai Intézet(Current)

Semmelweis University

Hungarian Academy of Sciences

National Institute of Oncology

Medical University of Vienna

Gyula Ostoros is an author at Országos Korányi Tbc és Pulmonológiai Intézet specializing in medicine, lung cancer, and oncology.

ORCID

Top concepts

Publications per year

2002–2024

37

Publications

37

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.4K citations · Full text

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 574 citations · Full text

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Jean‐Yves Douillard, Gyula Ostoros, Manuel Cobo et al. · Journal of Thoracic Oncology · 2014 · 441 citations · Full text

Rows per page

1–5 of 37